Possible therapy for ALS based on the cyanobacteria/BMAA hypothesis

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Although the cyanobacteria/BMAA hypothesis of the cause of ALS and other age-related neurodegenerative diseases remains to be proven, it is not too early to ask whether treatment would be possible if the hypothesis were correct. This paper reviews the possible ways that chronic BMAA neurotoxicity could be prevented or treated.

Original languageEnglish (US)
Pages (from-to)118-123
Number of pages6
JournalAmyotrophic Lateral Sclerosis
Issue numberSUPPL. 2
StatePublished - 2009


  • Aminoacyl-tRNA synthetase
  • Amyotrophic lateral sclerosis (ALS)
  • Blood-brain barrier
  • BMAA
  • Therapeutic trial

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology


Dive into the research topics of 'Possible therapy for ALS based on the cyanobacteria/BMAA hypothesis'. Together they form a unique fingerprint.

Cite this